NEWARK, Del, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to a recent market study by Future Market Insights (FMI), the global contrast media injectors market is expected to thrive at a 6.6% CAGR, reaching US$ 1.6 billion by 2023, and is anticipated to reach US$ 3.0 billion by 2033.
The contrast media injectors market has witnessed significant growth in recent years, driven by the increasing demand for advanced medical imaging techniques and the rising prevalence of chronic diseases. Contrast media injectors, also known as contrast delivery systems or contrast agents, play a crucial role in enhancing the visibility of internal body structures during diagnostic imaging procedures.
These injectors aid in obtaining clearer and more accurate images, enabling healthcare professionals to make better-informed decisions about patient diagnosis and treatment.
Request for Sample of this Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-823
The growing aging population and the increasing prevalence of chronic diseases, such as cardiovascular disorders, cancer, and neurological conditions, have led to a surge in the demand for diagnostic imaging procedures.
Contrast media injectors play a pivotal role in various imaging modalities like computed tomography (CT), magnetic resonance imaging (MRI), and angiography, facilitating early and accurate disease detection.
Key Takeaways from the Market Study
- At present, there are several media injectors available in the market that can efficiently be connected to the hospital’s IT system. The IT system is able to directly access data from the hospital information systems (HIS) or electronic medical record (EMR) systems to adjust the dose, thus reducing human error.
- Contrast media is expected to help in improving the diagnostic value for getting imaging clearance. It helps distinguish selected areas of the body from surrounding tissues. Therefore, healthcare professionals make it compulsory to undergo radiological testing with contrast media to come on any closing statement for a particular disease.
- The majority of hospitals and ambulatory surgical centers conduct radiological procedures utilizing contrast media for patients with chronic diseases, accidents, and autoimmune diseases. All these patients mostly prefer to go to hospitals for testing in order to get a proper diagnosis of the disease.
Regional Analysis
- The United States is anticipated to dominate the global contrast media injectors market by accounting for around 89.5% of the North American market in 2022.
- The growth of the United States market is attributed to favorable reimbursement policies, an increased aging population, a rise in the regulatory approval of an increasing number of contrasts agents, and increasing government funding. The healthcare business in the country is one of the well-known markets, in terms of product accessibility and innovations.
- Germany is another market exhibiting lucrative growth over the assessment period by accounting for around 25.8% of the Western Europe contrast media injectors market in 2022, as a result of its well-established healthcare infrastructure.
Competitive Landscape
Prominent companies operating in the contrast media injectors market are competitive by nature, with the presence of a handful of players. These players are involved in several strategic alliances.
The contrast media injector’s market players are testing out every possible mode of organic and inorganic growth in order to sustain themselves within the market. The product launch and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market.
Scope of the Report:
| Attribute | Details |
| Forecast Period | 2016 to 2022 |
| Historical Data Available for | 2023 to 2033 |
| Market Analysis | USD Billion for Value and Units for Volume |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Italy, Spain, Poland, Russia, Greater China, Japan, India, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product Type, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Attain Greater Consciousness Through Our Enlightening Methodology-Guided Insights! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-823
Contrast Media Injectors Market by Category:
By Product Type:
- CT Injectors
- MRI Injectors
- Cardio Injectors
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Centers
- Others
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Market Insights Domain:
Auto-Injectors Market Share: By 2033, the market is anticipated to surge to an impressive US$ 67,200.1 million. The auto-injector market size is expected to rise at a commendable CAGR of 8.2% from 2023 to 2033.
Large Volume Wearable Injectors Market Growth: Global Large Volume Wearable Injectors demand is anticipated to be valued at US$ 2,800.0 Million in 2022, forecast to grow at a CAGR of 8.9% to be valued at US$ 7,142.3 Million from 2022 to 2032.
Needle-Free Injectors Market Size: Global demand for Needle-Free Injectors is expected to rise at a yearly growth rate of 12% Y-o-Y to US$ 42.79 Billion in 2032.
Wearable Injectors Market Trends: The wearable injectors market is expected to be valued at over US$ 6.40 billion in 2022 and is anticipated to grow at a CAGR of 12.3% to reach US$ 19.70 billion by 2032.
Disposable Pen Injectors Market Demand: The disposable pen injectors market size is projected to be worth US$ 25.5 billion in 2023. The market is likely to surpass US$ 54.4 billion by 2033 at a CAGR of 7.9% during the forecast period.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
